Author

Shailendra Mani

Translational Health Science and Technology InstituteORCID 0000-0001-8541-8315Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Abhisek DwivedyiD· 1 shared Bhisma Narayan Panda· 1 shared Bichitra Kumar BiswaliD· 1 shared C. T. Ranjith-KumariD· 1 shared Debasis NayakiD· 1 shared Deepsikha KariD· 1 shared Farha Mehdi· 1 shared Garima Joshi· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Abhisek DwivedyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyiSciencePeer-reviewedSep 4, 2025

Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2

Oinam Ningthemmani Singh, Umang Berry, Garima Joshi…·Milan Surjit

This study compares self-amplifying and circular mRNA vaccines for SARS-CoV-2, finding that circular mRNA induces stronger memory T-cell responses and is stable at higher temperatures.

13 citationstop 1%

mouseproteomics

𝕏 PostBluesky

BioinformaticsPLoS Computational BiologyPeer-reviewedSep 13, 2021

Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2

Abhisek Dwivedy, Richard Mariadasse, Mohammed Ahmad…·Bichitra Kumar Biswal

This study characterizes the NiRAN domain of SARS-CoV-2 RdRp, identifies its kinase-like activity, and predicts potential inhibitors for drug repurposing.

29 citations

virusstatistical model

𝕏 PostBluesky